Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,913 | -221,315 | -160,112 | -103,858 | -43,473 |
| Depreciation Amortization | 25 | 89 | 67 | 47 | 27 |
| Accounts payable and accrued liabilities | 356 | 2,015 | 486 | 667 | 3,704 |
| Other Working Capital | -6,186 | 15,479 | 16,165 | 7,195 | 4,198 |
| Other Operating Activity | 7,550 | 61,626 | 49,961 | 32,813 | 5,410 |
| Operating Cash Flow | $-61,168 | $-142,106 | $-93,433 | $-63,136 | $-30,134 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 160,532 | -190,195 | -273,691 | -180,141 | 19,875 |
| PPE Investments | -422 | -139 | -125 | -67 | -4 |
| Other Investing Activity | 0 | -15,007 | -15,007 | 0 | 0 |
| Investing Cash Flow | $160,110 | $-205,341 | $-288,823 | $-180,208 | $19,871 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,677 | 481,227 | 480,339 | 200,697 | 485 |
| Other Financing Activity | 0 | -100,000 | -75,500 | 0 | 0 |
| Financing Cash Flow | $7,677 | $381,227 | $404,839 | $200,697 | $485 |
| Exchange Rate Effect | 38 | -18 | 90 | -24 | -36 |
| Beginning Cash Position | 105,187 | 71,425 | 71,425 | 71,425 | 71,425 |
| End Cash Position | 211,844 | 105,187 | 94,098 | 28,754 | 61,611 |
| Net Cash Flow | $106,657 | $33,762 | $22,673 | $-42,671 | $-9,814 |
| Free Cash Flow | |||||
| Operating Cash Flow | -61,168 | -142,106 | -93,433 | -63,136 | -30,134 |
| Capital Expenditure | -422 | -139 | -125 | -67 | -4 |
| Free Cash Flow | -61,590 | -142,245 | -93,558 | -63,203 | -30,138 |